On the Record · Veradigm
Veradigm acquisitions, on the record
The businesses Veradigm bought and sold, as its annual reports describe them, with the cash it reported paying for acquisitions each year and every deal filing since 2016.
Deals its annual reports describe
| Business | Deal | When | Value |
|---|---|---|---|
2bPrecise businessWord for word“We divested our 2bPrecise business to a third party for a non-controlling interest in the combined entity.” 10-K for 2021 | divestiture | — | — |
EPSiWord for word“On October 15, 2020 and December 31, 2020, we completed the sale of the EPSi and CarePort businesses, respectively.” 10-K for 2021 | divestiture | On October 15, 2020 | — |
CarePortWord for word“On October 15, 2020 and December 31, 2020, we completed the sale of the EPSi and CarePort businesses, respectively.” 10-K for 2021 | divestiture | December 31, 2020 | — |
Allscripts Hospitals and Large Physician Practice (HLPP) businessWord for word“On May 2, 2022, Veradigm completed the sale of the net assets of the Allscripts Hospitals and Large Physician Practice (“HLPP”) business to Altera Digital Health Inc. (formerly known as Harris Dawn Holdings Inc. and a wholly-owned subsidiary of Constellation Software Inc.” 10-K for 2022 | agreed divestiture | May 2, 2022 | — |
Koha HealthWord for word“On January 2, 2024, Veradigm announced its acquisition of Koha Health, a full-service revenue cycle management company.” 10-K for 2022 | agreed acquisition | January 2, 2024 | — |
Cascade Bio, Inc., which does business as ScienceIO ("ScienceIO")Word for word“On March 4, 2024, Veradigm completed its acquisition of Cascade Bio, Inc., which does business as ScienceIO (“ScienceIO”).” 10-K for 2022 | acquisition | March 4, 2024 | — |
Babel Health, Inc. ("Babel Health")Word for word“Net cash provided by investing activities - continuing operations for the year ended December 31, 2022, increased compared to the prior year, primarily due to the cash received as a result of the sale of the HLPP business, which was partially offset by the cash paid for the acquisition of Babel Health, Inc. (“Babel Health”).” 10-K for 2022 | acquisition | Year Ended December 31, 2022 | — |
Cascade Bio, Inc. (ScienceIO)Word for word“The total consideration was $ 106.2 million, consisting of $ 97.2 million of cash, plus the fair value of deferred merger consideration of $ 9.0 million, payable on the first, second, and third anniversaries following the acquisition date.” 10-K for 2024 | acquisition | — | $ 106.2 million |
| Fiscal year ended | Cash paid for acquisitions (net of cash acquired) | Goodwill from acquisitions |
|---|---|---|
| 2016-12-31 | $99.8 million | $703.1 million |
| 2017-12-31 | $169.8 million | $79.9 million |
| 2018-12-31 | $177.2 million | $95.6 million |
| 2019-12-31 | $23.4 million | $13.7 million |
| 2020-12-31 | $0 | — |
| 2021-12-31 | $0 | — |
| 2022-12-31 | $32 million | $34.3 million |
| 2023-12-31 | −$10,000 | — |
| 2024-12-31 | $107.3 million | $90.5 million |
Deal filings since 2016
- 2026-02-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2026-01-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-08-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-07-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-06-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-03-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-03-18 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-02-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2025-02-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-07-29 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-05-13 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-04-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-02-27 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-02-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2024-01-31 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2023-11-24 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-05-05 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2022-05-02 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2022-03-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-06-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2021-01-04 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2020-12-01 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-10-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-10-15 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2020-08-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2020-01-28 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-12-20 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-12-09 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2019-01-07 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2018-12-11 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-05-03 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-04-05 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-02-16 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-02-15 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2018-01-08 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2017-10-02 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2017-08-31 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2017-08-04 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-11-01 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2016-04-25 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
- 2016-04-25 Form 8-K, Item 2.01: Completion of Acquisition or Disposition of Assets
- 2016-03-23 Form 8-K, Item 1.01: Entry into a Material Definitive Agreement
Read from Veradigm’s annual reports (10-K for 2024, 10-K for 2022, 10-K for 2021) and the financial data it files with the SEC, as of 2026-05-26. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.